awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38856951-EF1B03CC-3921-4B6F-BF55-157F588F5303
Q38856951-EF1B03CC-3921-4B6F-BF55-157F588F5303
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38856951-EF1B03CC-3921-4B6F-BF55-157F588F5303
Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies.
P2860
Q38856951-EF1B03CC-3921-4B6F-BF55-157F588F5303
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38856951-EF1B03CC-3921-4B6F-BF55-157F588F5303
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e50438bc681efcb23d94a0b9e34037edf4ccc8aa
P2860
Preclinical pharmacokinetic properties of the P-glycoprotein inhibitor GF120918A (HCl salt of GF120918, 9,10-dihydro-5-methoxy-9-oxo-N-[4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]phenyl]-4-acridine-carboxamide) in the mouse, rat, d